CuraScientific Corp.
CSTF
$0.00
$0.000.00%
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -47.83% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -47.83% | -- | |||
| Cost of Revenue | 60.87% | 229.80% | |||
| Gross Profit | -960.98% | 64.47% | |||
| SG&A Expenses | -68.92% | 590.67% | |||
| Depreciation & Amortization | 4.26% | 23.68% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.27% | 403.63% | |||
| Operating Income | 17.40% | -256.74% | |||
| Income Before Tax | -113.85% | 19,182.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -113.85% | 19,182.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -113.85% | 19,182.25% | |||
| EBIT | 17.40% | -256.74% | |||
| EBITDA | 74.07% | -439.65% | |||
| EPS Basic | -101.95% | 1,328.71% | |||
| Normalized Basic EPS | -100.42% | 459.48% | |||
| EPS Diluted | -102.62% | 1,014.83% | |||
| Normalized Diluted EPS | -100.57% | 316.38% | |||
| Average Basic Shares Outstanding | 614.08% | 1,454.09% | |||
| Average Diluted Shares Outstanding | 431.23% | 1,989.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
